RET/PTC rearrangements were present in 4.6% of all series, being 67% in CV-PTC (6 cases), 22% in aggressive variants of PTC (1 diffuse sclerosing PTC and 1 solid trabecular), and 11% found in FTC (1 case). This evidence concerns the gene RET and thyroid cancer, nonmedullary, 2.